Rocket Lab USA (NASDAQ:RKLB) reported quarterly sales of $27.50 million which beat the analyst consensus estimate of $24.17 million by 13.78 percent.
Related Posts
AtriCure Q3 EPS $(0.27) Misses $(0.25) Estimate, Sales $83.20M Beat $81.33M Estimate
AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is a 17.39 percent decrease over losses of $(0.23) per share from the same
B of A Securities Upgrades Eastman Chemical to Buy, Announces $140 Price Target
B of A Securities analyst Matthew DeYoe upgrades Eastman Chemical (NYSE:EMN) from Neutral to Buy and announces $140 price target.
Jefferies Initiates Coverage On Enel with Underperform Rating
Jefferies initiates coverage on Enel (OTC:ENLAY) with a Underperform rating.